Kaplan–Meier analysis revealed that APCN expression correlated with a significantly shorter DSS, with the worst outcome for patients with high APCN tumor expression, both in test and validation series (Fig. 2A, B). This evidence concerns the gene FAM171A1 and neoplasm.